Treatment of retroauricular keloids: Revision of cases treated at the ENT service of HC/UFPR

INTRODUCTION  Keloids are benign tumors arising from abnormal healing of the skin, and there are several procedures available for their treatment. OBJECTIVE  The objective of this study was to evaluate the outcomes of patients undergoing treatment of keloids after ear, nose, and throat (ENT) surgeries at our service center. METHOD  We conducted thorough, retrospective and prospective analysis of records of patients undergoing treatment of retroauricular keloids at our center. RESULTS  Nine patients were evaluated, and 6 underwent resection and adjuvant beta-therapy, 2 underwent resection with local application of corticosteroids, and only 1 underwent resection without adjuvant therapy. There was no recurrence of keloids in patients that were treated with beta-therapy in the early postoperative period. One patient had relapsed despite corticosteroid administration and late beta-therapy. DISCUSSION  Several techniques have been used for the treatment of retroauricular keloids, and beta-therapy is thought to yield the best results, followed by the use of intralesional corticosteroids. CONCLUSION  Treatment of retroauricular keloids remains a challenge. While new techniques are being developed, resection followed by early beta-therapy is still the best treatment option.